NFKB1 and neoplasm: To eliminate TICs and reverse chemoresistance in gastric cancer, we explored the combination of the ITGB1 inhibitor LDV and the NF-κB inhibitor JSH-23 along with a chemotherapeutic agent to suppress tumor growth.